Acrivon Therapeutics (ACRV) Q1 2025 Earnings

Mar 27Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.84
-0.73
-0.63
-0.52

Details

Expected EPS
-0.663644
Actual EPS
-0.6
Surprise EPS
0.06
Surprise Percent
+9.59%

Description

⁨Acrivon Therapeutics⁩ (⁦ACRV⁩) has reported earnings of ⁦-0.6⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts